Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-121104
Filing Date
2024-11-05
Accepted
2024-11-05 09:06:00
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20240930.htm   iXBRL 10-Q 2284203
2 EX-31.1 beam-ex31_1.htm EX-31.1 17370
3 EX-32.1 beam-ex32_1.htm EX-32.1 9711
  Complete submission text file 0000950170-24-121104.txt   9805544

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20240930.xsd EX-101.SCH 1400409
79 EXTRACTED XBRL INSTANCE DOCUMENT beam-20240930_htm.xml XML 1912556
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 241425936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)